148 related articles for article (PubMed ID: 31005389)
1. CD30L/CD30 protects against psoriasiform skin inflammation by suppressing Th17-related cytokine production by Vγ4
Yue D; You Y; Zhang X; Wang B; Wang X; Qi R; Yang F; Meng X; Yoshikai Y; Wang Y; Sun X
J Autoimmun; 2019 Jul; 101():70-85. PubMed ID: 31005389
[TBL] [Abstract][Full Text] [Related]
2. CD30L/CD30 is critical for maintenance of IL-17A-producing γδ T cells bearing Vγ6 in mucosa-associated tissues in mice.
Sun X; Shibata K; Yamada H; Guo Y; Muta H; Podack ER; Yoshikai Y
Mucosal Immunol; 2013 Nov; 6(6):1191-201. PubMed ID: 23549449
[TBL] [Abstract][Full Text] [Related]
3. CD30 is required for activation of a unique subset of interleukin-17A-producing γδ T cells in innate immunity against Mycobacterium bovis Bacillus Calmette-Guerin infection.
Guo Y; Sun X; Shibata K; Yamada H; Muta H; Podack ER; Yoshikai Y
Infect Immun; 2013 Oct; 81(10):3923-34. PubMed ID: 23918785
[TBL] [Abstract][Full Text] [Related]
4. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.
Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Yoshikai Y
J Immunol; 2010 Aug; 185(4):2222-30. PubMed ID: 20639486
[TBL] [Abstract][Full Text] [Related]
5. CD30 ligand is a new therapeutic target for central nervous system autoimmunity.
Shinoda K; Sun X; Oyamada A; Yamada H; Muta H; Podack ER; Kira J; Yoshikai Y
J Autoimmun; 2015 Feb; 57():14-23. PubMed ID: 25533628
[TBL] [Abstract][Full Text] [Related]
6. CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses.
Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Iwakura Y; Yoshikai Y
J Immunol; 2010 Dec; 185(12):7671-80. PubMed ID: 21068411
[TBL] [Abstract][Full Text] [Related]
7. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
8. CD30L/CD30 signaling regulates the formation of the tumor immune microenvironment and inhibits intestinal tumor development of colitis-associated colon cancer in mice.
Wang X; Gao Y; Zhang X; Wang X; Wang B; Meng X; Yoshikai Y; Wang Y; Sun X
Int Immunopharmacol; 2020 Jul; 84():106531. PubMed ID: 32353687
[TBL] [Abstract][Full Text] [Related]
9. A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection.
Tang C; Yamada H; Shibata K; Muta H; Wajjwalku W; Podack ER; Yoshikai Y
J Immunol; 2008 Nov; 181(9):6316-27. PubMed ID: 18941223
[TBL] [Abstract][Full Text] [Related]
10. STAT3 but not STAT4 is critical for γδT17 cell responses and skin inflammation.
Agerholm R; Rizk J; Viñals MT; Bekiaris V
EMBO Rep; 2019 Nov; 20(11):e48647. PubMed ID: 31549795
[TBL] [Abstract][Full Text] [Related]
11. AhR modulates the IL-22-producing cell proliferation/recruitment in imiquimod-induced psoriasis mouse model.
Cochez PM; Michiels C; Hendrickx E; Van Belle AB; Lemaire MM; Dauguet N; Warnier G; de Heusch M; Togbe D; Ryffel B; Coulie PG; Renauld JC; Dumoutier L
Eur J Immunol; 2016 Jun; 46(6):1449-59. PubMed ID: 27000947
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Mitochondrial Translation Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation by Targeting Vγ4+ γδ T Cells.
Dhillon-LaBrooy A; Braband KL; Tantawy E; Rampoldi F; Kao YS; Boukhallouk F; Velasquez LN; Mamareli P; Silva L; Damasceno LEA; Weidenthaler-Barth B; Berod L; Almeida L; Sparwasser T
J Invest Dermatol; 2024 Apr; 144(4):844-854.e2. PubMed ID: 37832844
[TBL] [Abstract][Full Text] [Related]
13. Reduction of CD18 promotes expansion of inflammatory γδ T cells collaborating with CD4+ T cells in chronic murine psoriasiform dermatitis.
Gatzka M; Hainzl A; Peters T; Singh K; Tasdogan A; Wlaschek M; Scharffetter-Kochanek K
J Immunol; 2013 Dec; 191(11):5477-88. PubMed ID: 24190659
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A-Producing γδ T Cells.
Shi Z; Wu X; Yu S; Huynh M; Jena PK; Nguyen M; Wan YY; Hwang ST
J Invest Dermatol; 2020 Sep; 140(9):1815-1823. PubMed ID: 32057839
[TBL] [Abstract][Full Text] [Related]
15. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
16. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.
Fischer M; Harvima IT; Carvalho RF; Möller C; Naukkarinen A; Enblad G; Nilsson G
J Clin Invest; 2006 Oct; 116(10):2748-56. PubMed ID: 16964309
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice.
Yoo JK; Choo YK; Kwak DH; Lee JM; Lim CY; Lee JH; Park MY; Kim CH
Immunol Lett; 2016 Oct; 178():131-9. PubMed ID: 27592361
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptors in the pathogenesis and therapy of psoriasis.
Mabuchi T; Chang TW; Quinter S; Hwang ST
J Dermatol Sci; 2012 Jan; 65(1):4-11. PubMed ID: 22177422
[TBL] [Abstract][Full Text] [Related]
19. Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis.
Mabuchi T; Takekoshi T; Hwang ST
J Immunol; 2011 Nov; 187(10):5026-31. PubMed ID: 21984702
[TBL] [Abstract][Full Text] [Related]
20. Essential Role for CD30-Transglutaminase 2 Axis in Memory Th1 and Th17 Cell Generation.
Suzuki AS; Yagi R; Kimura MY; Iwamura C; Shinoda K; Onodera A; Hirahara K; Tumes DJ; Koyama-Nasu R; Iismaa SE; Graham RM; Motohashi S; Nakayama T
Front Immunol; 2020; 11():1536. PubMed ID: 32793209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
